Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	147.47	205.69	288.19	754.96	178.51
Revenue Growth (YoY)	-40.42%	-28.63%	-61.83%	322.92%	-
Cost of Revenue	-74.06	-21.82	113.55	584.29	115.68
Gross Profit	221.52	227.51	174.64	170.67	62.83
Selling, General & Admin	26.4	37.53	25.42	29.42	17.75
Other Operating Expenses	5.54	-9.85	-39.48	-2.48	-0.05
Operating Expenses	65.03	44.58	-14.63	26.95	17.7
Operating Income	156.5	182.92	189.27	143.73	45.13
Interest Expense	-2.08	-10.27	-0.33	-1.1	-1.25
Interest & Investment Income	0.01	1.12	0.27	-	-
Earnings From Equity Investments	-12.08	-6.92	-31.11	-	-
Currency Exchange Gain (Loss)	-0.07	-0.1	-0.28	-0.05	-
Other Non Operating Income (Expenses)	-287.97	4.53	-2.99	-0.75	-
EBT Excluding Unusual Items	-145.69	171.28	154.83	141.82	43.88
Gain (Loss) on Sale of Investments	-	-	51.73	-1.31	1.63
Gain (Loss) on Sale of Assets	-	-	-	-	-3.12
Asset Writedown	-3.51	-4.28	1.22	-1.63	-
Pretax Income	-149.2	166.99	207.78	138.88	42.38
Income Tax Expense	-11.52	-0.38	-	-	-
Net Income	-137.68	167.37	207.78	138.88	42.38
Net Income to Common	-137.68	167.37	207.78	138.88	42.38
Net Income Growth	-	-19.45%	49.61%	227.67%	-
Shares Outstanding (Basic)	6,068	6,045	5,235	5,140	-
Shares Outstanding (Diluted)	6,068	6,045	5,235	5,140	-
Shares Change (YoY)	6.69%	15.48%	1.85%	-	-
EPS (Basic)	-0.02	0.03	0.04	0.03	-
EPS (Diluted)	-0.02	0.03	0.04	0.03	-
EPS Growth	-	-30.24%	46.91%	-	-
Free Cash Flow	13.31	-112.35	-166.79	145.64	-52.47
Free Cash Flow Per Share	0.00	-0.02	-0.03	0.03	-
Gross Margin	150.22%	110.61%	60.60%	22.61%	35.20%
Operating Margin	106.13%	88.93%	65.67%	19.04%	25.28%
Profit Margin	-93.36%	81.37%	72.10%	18.39%	23.74%
Free Cash Flow Margin	9.03%	-54.62%	-57.88%	19.29%	-29.39%
EBITDA	187.44	197.22	189.98	145.16	47.18
EBITDA Margin	127.11%	95.88%	65.92%	19.23%	26.43%
D&A For EBITDA	30.94	14.3	0.72	1.44	2.04
EBIT	156.5	182.92	189.27	143.73	45.13
EBIT Margin	106.13%	88.93%	65.67%	19.04%	25.28%
Advertising Expenses	-	1.34	3.2	0.26	0.11

Updated Feb 16, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.